Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of Hepatology
1007-3418
2007 Issue 11
Effects of rhein on nonalcoholic steatohepatitis in rats
YING Wei-xing;ZHU Chou-wen;LI Rong-zhou
..............page:869-870
Preparation and characterization of a murine monoclonal antibody against human ALDH1A1
QU Hai-xia;YANG Jin-ju;LIU Ying;LIU Xiao-lan;Gian P.Visentin;GAO Jian-en;HU He-ping;SUN Qi-hong
..............page:867-868
Effect of TIMP-1 siRNA on liver fibrosis in rats under ultrasound microbubble and ultrasound irradiation
TIAN Li;ZHAO Guo-qiang;YUAN Jian-jun;LI Ji-chang;CHEN Kui-sheng;CAI Qing-chun
..............page:865-866
Correlations between intrahepatic CD4+,CD8+,and virus-specific CD8+T cells and liver injury in chronic severe hepatitis
ZHANG Yao;WANG Yu-ming;ZHOU Ji-jun;XIA Jie;YANG Zhan-yu;WANG Shu-guang
..............page:863-864
17 β-estradiol inhibites the development of rat liver fibrosis by enhancing expression of hepatocyte growth factor
DENG Jin-yu;HE Sheng;SUN Dan
..............page:861-862
Expression of PPAR-gamma in rat liver fibrosis and the effect of Dan-shao-hua-xian Capsule on its expression pattern
WANG He-yan;ZHOU Xiao-qian;CHENG Ming-liang
..............page:859-860
OKT3 for recipients with steroid-resistant acute rejection after liver transplantation
WU Lin-wei;HE Xiao-shun;ZHU Xiao-feng;WANG Dang-ping;JU Wei-qiang;TAI Qiang;HUANG Jie-fu
..............page:857-858
Treatment of hepatic cysts with percutaneous injections of acetic acid
ZHANG Pei-yi;SHI Chun-lin;CHEN Peng;HU Li-hua;LIU Ying;JIANG Hong;YU Jing
..............page:856-857
Effect and mechanism of reduced glutathione treatment on liver functional impairments in experimental severe acute pancreatitis in rats
XUE Yu-zheng;LIU Zong-liang;HUANG Zhong-wei;YIN Qun;ZHANG Ping-fang;LI Hang;LU Yu-feng
..............page:854-855
Detection of titers and replications of HBV DNA in peripheral blood mononuclear cells and bone marrow CD34+cells in liver transplant recipients receiving prophylactic combined lamivudine and hepatitis B immunoglobulin treatments
LAI Wei;LU Shi-chun;LI You-ping;ZHAO Ji;DAI Jun;JIN Sheng-jie
..............page:852-853
The value of interferon-a in the management of hepatocellular carcinoma
SUN Hui-chuan
..............page:850-851
Interferons for treating chronic hepatitis B
JIA Ji-dong;ZHENG Huan-wei
..............page:849-850
Interferons and chronic hepatitis C treatment
CAI Da-chuan;REN Hong
..............page:847-848
Mechanisms of the actions of interferons
ZHU You-fu;HE Yu-kai
..............page:845-846
Molecular mechanism of ciglitazone inhibiting the expression of extracellular matrix in human hepatic stellate cells
ZHAO Cai-yan;ZHOU Jun-ying;YANG Liu;WANG Ya-dong
..............page:840-844
The relationship between the opening of mitochondrial permeability transition pores of cultured hepatocytes with their apoptoses in a non-alcoholic fatty liver disease model
CHEN Dong-feng;WANG Chun-hua
..............page:837-839
Pulmonary infection and its risk factors after orthotopic liver transplantation
SHEN Ying-hao;FAN Jia;ZHOU Jian;WU Zhi-quan;QIU Shuang-jian;HUANG Xiao-wu;SUN Jian;WANG Ting;SHI Ying-hong
..............page:833-836
Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma and their significance in clinical settings
TONG Guang-dong;ZHOU Da-qiao;HE Jin-song;XIAO Chun-ling;HU Xin-liang;ZHOU Xiao-zhou;ZHANG Xi;XING Yu-feng;LU Ping;Mark A.Feitelson
..............page:828-832
Effect of epigallocatechin-3-gallate on the invasiveness of hepatocarcinoma cells in vitro
LU Li;LIU Hui-min;TANG Wei-xue
..............page:825-827
A clinical study of adefovir dipivoxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period
YANG Qing;GONG Zuo-jiong;HU Dan-feng
..............page:821-824
Preparation and application of oligo microarrays for hepatitis virus detection and genotyping
SUN Zhao-hui;YANG Hui-lan;WEI Min;WANG Shu-yan;WANG Cong-rong;SHI Yu-ling;MA Wen-li
..............page:816-820
Serum level of HMGB1 in patients with hepatitis B and its clinical significance
LIU Hong-bo;FAN Xue-gong;HUANG Jian-jun;LI Ning;PENG Jian-ping;LI Sha-ling;Haichao WANG
..............page:812-815
A clinical analysis of HBV reactivation in patients with malignant tumors
MA Li-na;SUN Gui-zhen;DONG Jin-ling;HUANG Chun-yang;CHEN Xin-yue
..............page:809-811
Liver transplantation for chronic hepatitis B patients with lamivudine monotherapy or lamivudine combined with individualized low-dose hepatitis B immunoglobulin treatment
JIAO Zuo-yi;YAN Lü-nan;LI Bo;ZENG Yong;WEN Tian-fu;LU Shi-chun;ZHAO Ji-chun;WANG Wen-tao;XU Ming-qing;YANG Jia-yin;LI Zhi-hui;MA Yu-kui;ZHANG Zhong-wei;CHEN Zhe-yu
..............page:804-808
Interferons 50 years and liver diseases
ZHANG Ding-feng
..............page:801-803
xiao xi
..............page:811,872
Progress in the study of proteasome inhibitor inducing hepatic stellate cell apoptosis
ZHANG Yong-jin;FANG Bu-wu
..............page:878-880
Report of an international workshop: roadmap for management of patients receiving oral therapy for chronic hepatitis B
ZHANG Da-zhi
..............page:876-877
A case report of successful reestablishment of immunity to HBV after liver transplantation
LU Shi-chun;LAI Wei;DAI Jun;LIU Yuan;WANG Meng-long;LI Ning
..............page:874-875
Effects of Chinese herb compound hanfangji on rat liver fibrosis
QUAN Qi-zhen;WANG Yao-jun;QUAN Yuan;QUAN Hua;JIA Ai-qin;JIANG Xue-liang;SUN Zi-qin
..............page:873-874
Dynamic characteristics of PDGF-C during liver lipoid degeneration and fibrogenesis processes in rats
JIANG Feng;CHENG Ming-liang;ZHOU Xiao-qian
..............page:871-872
© 2006 Oriprobe Information Services, Inc. All rights reserved
Tel: 1-519-977 9050 | Email:info@oriprobe.com
Home | Survey | Payment | Talks & Presentations | Job Opportunities